These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39433148)

  • 1. Exploring the potential of reconstructed human epithelial tissue models for safety assessment of intraoral medical devices.
    Pôbiš P; Milasová T; Kandarova H
    Toxicol In Vitro; 2024 Oct; ():105956. PubMed ID: 39433148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Sensitive
    Pôbiš P; Kubalcová J; Milasová T; Kandárová H
    Altern Lab Anim; 2024 Sep; 52(5):261-275. PubMed ID: 39168512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-house validation of the EpiOcular(TM) eye irritation test and its combination with the bovine corneal opacity and permeability test for the assessment of ocular irritation.
    Kolle SN; Kandárová H; Wareing B; van Ravenzwaay B; Landsiedel R
    Altern Lab Anim; 2011 Sep; 39(4):365-87. PubMed ID: 21942548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISO 10993-23 In vitro irritation testing for medical devices: Substantiating applicability to mild irritants and non-extractables.
    Pellevoisin C; Coleman KP; Hoffmann S
    Toxicol In Vitro; 2022 Aug; 82():105371. PubMed ID: 35487444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Big Three" in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet?
    Kanďárová H; Pôbiš P
    Front Toxicol; 2023; 5():1337468. PubMed ID: 38259728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts.
    Pellevoisin C; Videau C; Briotet D; Grégoire C; Tornier C; Alonso A; Rigaudeau AS; Bouez C; Seyler N
    Toxicol In Vitro; 2018 Aug; 50():418-425. PubMed ID: 29339149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suitability of reconstructed human epidermis models for medical device irritation assessment: A comparison of In Vitro and In Vivo testing results.
    De Jong WH; Carraway JW; Liu C; Fan C; Liu J; Turley AP; Rollins TS; Coleman KP
    Toxicol In Vitro; 2020 Dec; 69():104995. PubMed ID: 32891721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EpiOcular™ Eye Irritation Test is the Method of Choice for the In Vitro Eye Irritation Testing of Agrochemical Formulations: Correlation Analysis of EpiOcular Eye Irritation Test and BCOP Test Data According to the UN GHS, US EPA and Brazil ANVISA Classification Schemes.
    Kolle SN; Rey Moreno MC; Mayer W; van Cott A; van Ravenzwaay B; Landsiedel R
    Altern Lab Anim; 2015 Jul; 43(3):181-98. PubMed ID: 26256396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
    Costin GE; Hill E; Brown J; Clippinger AJ
    Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™.
    Kandarova H; Willoughby JA; De Jong WH; Letasiova S; Milasova T; Bachelor MA; Breyfogle B; Handa Y; De la Fonteyne L; Coleman KP
    Toxicol In Vitro; 2018 Aug; 50():407-417. PubMed ID: 29438733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an oral mucosal irritation test using a three-dimensional human buccal oral mucosal model.
    Aizawa S; Yoshida H; Umeshita K; Watanabe S; Takahashi Y; Sakane S; Sakaguchi H; Kataoka S
    Toxicol In Vitro; 2023 Mar; 87():105519. PubMed ID: 36403724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of polymer-based biomaterials and medical devices - regulations, in vitro screening and risk-management.
    Bernard M; Jubeli E; Pungente MD; Yagoubi N
    Biomater Sci; 2018 Jul; 6(8):2025-2053. PubMed ID: 29968869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation.
    Kaluzhny Y; Kandárová H; Hayden P; Kubilus J; d'Argembeau-Thornton L; Klausner M
    Altern Lab Anim; 2011 Sep; 39(4):339-64. PubMed ID: 21942547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of test method variables for in vitro skin irritation testing of medical device extracts.
    Olsen DS; Lee M; Turley AP
    Toxicol In Vitro; 2018 Aug; 50():426-432. PubMed ID: 29180040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoral medical devices for sustained drug delivery.
    Alghanem S; Dziurkowska E; Ordyniec-Kwaśnica I; Sznitowska M
    Clin Oral Investig; 2023 Dec; 27(12):7157-7169. PubMed ID: 37982874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro human skin irritation test for evaluation of medical device extracts.
    Casas JW; Lewerenz GM; Rankin EA; Willoughby JA; Blakeman LC; McKim JM; Coleman KP
    Toxicol In Vitro; 2013 Dec; 27(8):2175-83. PubMed ID: 23999410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EpiOcular Eye Irritation Test (EIT) for hazard identification and labelling of eye irritating chemicals: protocol optimisation for solid materials and the results after extended shipment.
    Kaluzhny Y; Kandárová H; Handa Y; DeLuca J; Truong T; Hunter A; Kearney P; d'Argembeau-Thornton L; Klausner M
    Altern Lab Anim; 2015 May; 43(2):101-27. PubMed ID: 25995013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.
    Kaluzhny Y; Klausner M
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):207-237. PubMed ID: 33544359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal irritation testing-prospects of human organotypic vaginal tissue culture models.
    Ayehunie S; Landry T; Armento A
    In Vitro Cell Dev Biol Anim; 2024 Jun; 60(6):569-582. PubMed ID: 38995526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the EpiOcular((TM)) Tissue Model as an Alternative to the Draize Eye Irritation Test.
    Stern M; Klausner M; Alvarado R; Renskers K; Dickens M
    Toxicol In Vitro; 1998 Aug; 12(4):455-61. PubMed ID: 20654428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.